<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
<journal-id journal-id-type="pmc">ploscomp</journal-id><journal-title-group>
<journal-title>PLoS Computational Biology</journal-title></journal-title-group>
<issn pub-type="ppub">1553-734X</issn>
<issn pub-type="epub">1553-7358</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PCOMPBIOL-D-13-00425</article-id>
<article-id pub-id-type="doi">10.1371/journal.pcbi.1003210</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories>
<title-group>
<article-title>How MicroRNA and Transcription Factor Co-regulatory Networks Affect Osteosarcoma Cell Proliferation</article-title>
<alt-title alt-title-type="running-head">MicroRNA and TF Co-regulation in Osteosarcoma</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Poos</surname><given-names>Kathrin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Smida</surname><given-names>Jan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nathrath</surname><given-names>Michaela</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Maugg</surname><given-names>Doris</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Baumhoer</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Korsching</surname><given-names>Eberhard</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Institute of Bioinformatics, University of Münster, Münster, Germany</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Clinical Cooperation Group Osteosarcoma, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Children's Cancer Research Center and Department of Pediatrics, Klinikum rechts der Isar, Technische Universität München, Munich, Germany</addr-line></aff>
<aff id="aff4"><label>4</label><addr-line>Bone Tumor Reference Center at the Institute of Pathology, University Hospital Basel, Basel, Switzerland</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Ioshikhes</surname><given-names>Ilya</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Ottawa University, Canada</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">korschi@uni-muenster.de</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: KP JS EK. Performed the experiments: KP JS. Analyzed the data: KP. Contributed reagents/materials/analysis tools: JS MN DM DB EK. Wrote the paper: KP JS EK.</p></fn>
</author-notes>
<pub-date pub-type="collection"><month>8</month><year>2013</year></pub-date>
<pub-date pub-type="epub"><day>29</day><month>8</month><year>2013</year></pub-date>
<volume>9</volume>
<issue>8</issue>
<elocation-id>e1003210</elocation-id>
<history>
<date date-type="received"><day>12</day><month>3</month><year>2013</year></date>
<date date-type="accepted"><day>19</day><month>7</month><year>2013</year></date>
</history>
<permissions>
<copyright-year>2013</copyright-year>
<copyright-holder>Poos et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract>
<p>Osteosarcomas (OS) are complex bone tumors with various genomic alterations. These alterations affect the expression and function of several genes due to drastic changes in the underlying gene regulatory network. However, we know little about critical gene regulators and their functional consequences on the pathogenesis of OS. Therefore, we aimed to determine microRNA and transcription factor (TF) co-regulatory networks in OS cell proliferation. Cell proliferation is an essential part in the pathogenesis of OS and deeper understanding of its regulation might help to identify potential therapeutic targets. Based on expression data of OS cell lines divided according to their proliferative activity, we obtained 12 proliferation-related microRNAs and corresponding target genes. Therewith, microRNA and TF co-regulatory networks were generated and analyzed regarding their structure and functional influence. We identified key co-regulators comprising the microRNAs <italic>miR-9-5p</italic>, <italic>miR-138</italic>, and <italic>miR-214</italic> and the TFs <italic>SP1</italic> and <italic>MYC</italic> in the derived networks. These regulators are implicated in <italic>NFKB</italic>- and <italic>RB1</italic>-signaling and focal adhesion processes based on their common or interacting target genes (e.g., <italic>CDK6</italic>, <italic>CTNNB1</italic>, <italic>E2F4</italic>, <italic>HES1</italic>, <italic>ITGA6</italic>, <italic>NFKB1</italic>, <italic>NOTCH1</italic>, and <italic>SIN3A</italic>). Thus, we proposed a model of OS cell proliferation which is primarily co-regulated through the interactions of the mentioned microRNA and TF combinations. This study illustrates the benefit of systems biological approaches in the analysis of complex diseases. We integrated experimental data with publicly available information to unravel the coordinated (post)-transcriptional control of microRNAs and TFs to identify potential therapeutic targets in OS. The resulting microRNA and TF co-regulatory networks are publicly available for further exploration to generate or evaluate own hypotheses of the pathogenesis of OS (<ext-link ext-link-type="uri" xlink:href="http://www.complex-systems.uni-muenster.de/co_networks.html" xlink:type="simple">http://www.complex-systems.uni-muenster.de/co_networks.html</ext-link>).</p>
</abstract>
<abstract abstract-type="summary"><title>Author Summary</title>
<p>Osteosarcomas (OS) are bone tumors most frequently affecting children and young adolescents. We do not know much about its molecular pathogenesis hampering personalized therapies to more effectively cure patients. To this day, almost all patients receive adjuvant chemotherapies independent of its necessity. Hence, we need to gain a comprehensive understanding of the molecular pathogenesis of OS to uncover molecular components that can be used as therapeutic targets. MicroRNAs and transcription factors (TFs) are master regulators of the cellular system. They control the amount of genes expressed in a cell at a specific time point that ultimately results in a distinct cellular phenotype. Here, we investigated microRNA and TF co-regulatory networks in OS cell growth as one hallmark in cancer. We uncovered key microRNA and TF regulators that cooperatively control growth-related pathways in OS and proposed potential therapeutic targets. This study illustrates the benefit of analyzing complex diseases from a network perspective because no molecular component functions isolated from the underlying cellular system.</p>
</abstract>
<funding-group><funding-statement>KP, JS, MN, DM, and EK were funded by the Translational Sarcoma Research Network supported by the BMBF (FKZ 01GM0870, 01GM0869) and KP, EK by European TRANSCAN I consortium - PROspective VAlidation of Biomarkers in Ewing Sarcoma for personalised translational medicine by BMBF (FZK 01KT1310). DB was supported by the Foundation for the Preservation of the Basel Bone Tumor Center. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="13"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Osteosarcoma (OS) is a rare type of cancer frequently occurring in children and young adolescents <xref ref-type="bibr" rid="pcbi.1003210-Picci1">[1]</xref>. It is a complex tumor typically accompanied by severe genomic instability and extensive mutations hampering the identification of a genetic root <xref ref-type="bibr" rid="pcbi.1003210-Man1">[2]</xref>–<xref ref-type="bibr" rid="pcbi.1003210-Smida1">[4]</xref>. These genomic alterations affect several genes to a varying extent depending on patient and OS subtype. For instance, frequent mutations and deletions of the tumor suppressor genes <italic>TP53</italic>, <italic>RB1</italic>, and <italic>CDKN2A</italic> and mutations and amplification of the <italic>MYC</italic> locus <xref ref-type="bibr" rid="pcbi.1003210-Scholz1">[5]</xref>, <xref ref-type="bibr" rid="pcbi.1003210-Ueda1">[6]</xref>. However, their interactions in the molecular pathogenesis and the underlying cellular network of OS are poorly characterized.</p>
<p>Recently, attention has been focused on the impact of microRNAs in OS. Besides transcription factors (TFs) that transcriptionally regulate gene expression, microRNAs are a class of small, conserved, non-coding RNA molecules generally acting on the post-transcriptional level. They are mono- or polycistronically transcribed, processed to mature molecules and subsequently incorporated into the RNA Induced Silencing Complex (RISC). Once integrated in RISC, microRNAs are able to select their target genes via binding to partially complementary sequences in the 3′-UTRs of mRNAs that lead to mRNA degradation or translational inhibition. Computational prediction methods revealed that individual microRNAs regulate hundreds of target genes and one target gene might be regulated by several microRNAs <xref ref-type="bibr" rid="pcbi.1003210-Selbach1">[7]</xref>. According to Friedman <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1003210-Friedman1">[8]</xref> around 60% of human genes are predicted to be regulated by multiple microRNAs in a cooperative manner. This huge number of target genes suggests a widespread control of biological processes including differentiation, proliferation, migration, and apoptosis <xref ref-type="bibr" rid="pcbi.1003210-Davis1">[9]</xref>.</p>
<p>In cancer, microRNAs might serve as onco- and/or tumor suppressor-microRNAs. Amplification or over-expression of oncogenic microRNAs can down-regulate tumor suppressor proteins. Likewise, deletion or under-expression of tumor suppressor microRNAs might lead to the up-regulation of oncogenes <xref ref-type="bibr" rid="pcbi.1003210-EsquelaKerscher1">[10]</xref>. In addition, more than 50% of microRNA genes are located within fragile sites in the genome and are frequently subjected to chromosomal alterations <xref ref-type="bibr" rid="pcbi.1003210-Calin1">[11]</xref>. In this manner, they can affect cancer development and progression.</p>
<p>MicroRNAs share several regulatory concepts with TFs, e.g. they simultaneously regulate many target genes and cooperate with other regulators. However, TFs activate or repress their target gene expression whereas microRNAs regulate their targets primarily through repression to fine-tune cell-specific gene regulatory programs <xref ref-type="bibr" rid="pcbi.1003210-Hobert1">[12]</xref>. Because the expression of microRNAs often depends on TF regulation and vice versa, it is not surprising that both families of regulators are tightly related to each other in gene regulatory networks. The coordinated transcriptional regulation of microRNAs and their target genes by TFs is a recurrent network motif. The two types of gene regulators frequently form 3-node feedforward loops (FFLs) with common target genes <xref ref-type="bibr" rid="pcbi.1003210-Shalgi1">[13]</xref>. Recently, Sun <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1003210-Sun1">[14]</xref> extended this regulatory motif to 4-node FFLs by integrating additional TF target genes. The extension of 3-node to 4-node motifs illustrated a more detailed model of the oncogenesis of glioblastoma by recruiting additional disease genes not directly targeted by microRNAs.</p>
<p>Several studies have shown an involvement of microRNAs in the pathogenesis of OS. They demonstrated down-regulation of <italic>miR-143</italic> in OS progression <xref ref-type="bibr" rid="pcbi.1003210-Zhang1">[15]</xref>, up-regulation of the oncogenic <italic>miR-17∼92</italic> cluster in OS cells <xref ref-type="bibr" rid="pcbi.1003210-Baumhoer1">[16]</xref>, and regulatory functions for <italic>miR-199a-3p</italic> <xref ref-type="bibr" rid="pcbi.1003210-Duan1">[17]</xref>, <italic>miR-21</italic> <xref ref-type="bibr" rid="pcbi.1003210-Ziyan1">[18]</xref>, and <italic>miR-125b</italic> <xref ref-type="bibr" rid="pcbi.1003210-Liu1">[19]</xref> in OS cell proliferation and migration. Additional genome-wide microRNA analyses suggested sets of microRNAs to discriminate OS from osteoblasts and bone tissue <xref ref-type="bibr" rid="pcbi.1003210-Jones1">[20]</xref>–<xref ref-type="bibr" rid="pcbi.1003210-Namls1">[23]</xref>. All studies proposed the use of microRNAs as biomarkers in OS that might correlate with clinico-pathological parameters. However, those studies lack a comprehensive analysis of the functional consequences of aberrant microRNA expression in OS. Analyzing microRNAs in the context of their microRNA and TF co-regulatory networks might provide a deeper understanding of the pathogenesis of OS.</p>
<p>In this study, we joined different data sources to analyze the contribution of microRNA and TF co-regulatory 3-node and 4-node motifs to the proliferative activity of OS cells. First, we divided seven OS cell lines into high and low proliferation groups by performing proliferation assays. Expression analysis based on these groups yielded differentially expressed (DE) microRNAs and mRNAs. Second, high efficacy microRNA target genes were obtained by integrating computational predicted targets with DE mRNAs. Only microRNAs with significantly enriched target genes were considered in the analysis. Third, microRNA target genes were clustered according to their functional similarity to explore their distinct biological processes. Fourth, transcription factor binding site (TFBS) information was added to assemble 3-node and 4-node motifs of non-random microRNA and TF co-regulator pairs. Fifth, the resulting 3-node and 4-node motifs were merged to form microRNA and TF co-regulatory networks to examine the coordinated regulation of microRNAs and TFs (<xref ref-type="fig" rid="pcbi-1003210-g001">Figure 1</xref>).</p>
<fig id="pcbi-1003210-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003210.g001</object-id><label>Figure 1</label><caption>
<title>Workflow.</title>
<p>The figure illustrates the procedure of the present study determining microRNA and TF co-regulation in OS cell proliferation.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003210.g001" position="float" xlink:type="simple"/></fig>
<p>Here, we present the first study analyzing microRNA and TF co-regulation in OS and uncover critical microRNA players of the functional processes implicated in OS cell proliferation.</p>
</sec><sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>OS cell proliferation and differential microRNA expression</title>
<p>In order to investigate the deregulated microRNA and TF co-regulatory networks of proliferative OS cells, we used seven authenticated OS cell lines. The cell lines were divided according to their proliferative activity by performing a proliferation assay. Four OS cell lines exhibited a high proliferative activity with a doubling time &lt;10 hours while three showed less proliferation (<xref ref-type="table" rid="pcbi-1003210-t001">Table 1</xref>). MNNG/HOS, U2-OS, and SJSA-1 showed additional extensive migratory capabilities. The expression analysis of the microRNAs was based on these two proliferation groups. The analysis yielded nine down-regulated and eight up-regulated microRNAs that passed the differential expression criteria (False discovery rate (FDR) &lt;0.05 &amp; log2 Fold change (FC)≥|1|, <xref ref-type="table" rid="pcbi-1003210-t002">Table 2</xref>). The derived DE microRNAs have been reported in association with neoplastic disease either due to oncogenic or tumor suppressor properties. Hierarchical clustering of them clearly separated the OS cell samples according to their proliferative activity (<xref ref-type="fig" rid="pcbi-1003210-g002">Figure 2</xref>). Hence, we selected the DE microRNAs as candidates that might affect OS cell proliferation for further analysis.</p>
<fig id="pcbi-1003210-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003210.g002</object-id><label>Figure 2</label><caption>
<title>Clustering of differentially expressed microRNAs.</title>
<p>The heatmap illustrates the expression profiles of DE microRNAs (log2 FC≥|1| &amp; FDR&lt;0.05, y-axis) among all OS cell samples (x-axis). High (dark blue) and low (light blue) proliferative OS samples are clearly separated. The red/green color code corresponds to the expression deviation from the average expression among all samples. Complete-linkage clustering was performed with the Pearson correlation as distance metric.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003210.g002" position="float" xlink:type="simple"/></fig><table-wrap id="pcbi-1003210-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003210.t001</object-id><label>Table 1</label><caption>
<title>Proliferation and migration potential of OS cell lines.</title>
</caption><alternatives><graphic id="pcbi-1003210-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003210.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Cell line</td>
<td align="left" rowspan="1" colspan="1">Proliferation</td>
<td align="left" rowspan="1" colspan="1">Migration</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">HOS-58</td>
<td align="left" rowspan="1" colspan="1">low</td>
<td align="left" rowspan="1" colspan="1">low</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SaOS-2</td>
<td align="left" rowspan="1" colspan="1">low</td>
<td align="left" rowspan="1" colspan="1">low</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">ZK-58</td>
<td align="left" rowspan="1" colspan="1">low</td>
<td align="left" rowspan="1" colspan="1">low</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">MG-63</td>
<td align="left" rowspan="1" colspan="1">high</td>
<td align="left" rowspan="1" colspan="1">low</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">MNNG/HOS</td>
<td align="left" rowspan="1" colspan="1">high</td>
<td align="left" rowspan="1" colspan="1">high</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SJSA-1</td>
<td align="left" rowspan="1" colspan="1">high</td>
<td align="left" rowspan="1" colspan="1">high</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">U2-OS</td>
<td align="left" rowspan="1" colspan="1">high</td>
<td align="left" rowspan="1" colspan="1">high</td>
</tr>
</tbody>
</table>
</alternatives></table-wrap><table-wrap id="pcbi-1003210-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003210.t002</object-id><label>Table 2</label><caption>
<title>Differentially expressed microRNAs dependent on OS cell proliferation.</title>
</caption><alternatives><graphic id="pcbi-1003210-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003210.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">microRNA</td>
<td align="left" rowspan="1" colspan="1">log2 FC</td>
<td align="left" rowspan="1" colspan="1">FDR</td>
<td align="left" rowspan="1" colspan="1">References</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">miR-181a</td>
<td align="left" rowspan="1" colspan="1">−2.28</td>
<td align="left" rowspan="1" colspan="1">0.000013</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003210-Jones1">[20]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-9-3p</td>
<td align="left" rowspan="1" colspan="1">−2.01</td>
<td align="left" rowspan="1" colspan="1">0.00443</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003210-Namls1">[23]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-181d</td>
<td align="left" rowspan="1" colspan="1">−1.82</td>
<td align="left" rowspan="1" colspan="1">0.000028</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003210-Namls1">[23]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-138</td>
<td align="left" rowspan="1" colspan="1">−1.81</td>
<td align="left" rowspan="1" colspan="1">0.03828</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003210-Wang1">[33]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-214</td>
<td align="left" rowspan="1" colspan="1">−1.59</td>
<td align="left" rowspan="1" colspan="1">0.03083</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003210-Jones1">[20]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-9-5p</td>
<td align="left" rowspan="1" colspan="1">−1.44</td>
<td align="left" rowspan="1" colspan="1">0.00525</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003210-Namls1">[23]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-181b</td>
<td align="left" rowspan="1" colspan="1">−1.17</td>
<td align="left" rowspan="1" colspan="1">0.000028</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003210-Jones1">[20]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">let-7f</td>
<td align="left" rowspan="1" colspan="1">−1.09</td>
<td align="left" rowspan="1" colspan="1">0.00211</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003210-Boyerinas1">[73]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-92b</td>
<td align="left" rowspan="1" colspan="1">−1.06</td>
<td align="left" rowspan="1" colspan="1">0.000149</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003210-Haug1">[74]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-130a</td>
<td align="left" rowspan="1" colspan="1">2.77</td>
<td align="left" rowspan="1" colspan="1">0.00698</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003210-Wang2">[75]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-21-5p</td>
<td align="left" rowspan="1" colspan="1">2.31</td>
<td align="left" rowspan="1" colspan="1">0.03760</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003210-Ziyan1">[18]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-155</td>
<td align="left" rowspan="1" colspan="1">2.05</td>
<td align="left" rowspan="1" colspan="1">0.00382</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003210-Jiang1">[76]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-222</td>
<td align="left" rowspan="1" colspan="1">1.87</td>
<td align="left" rowspan="1" colspan="1">0.00698</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003210-ChunZhi1">[77]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-221</td>
<td align="left" rowspan="1" colspan="1">1.45</td>
<td align="left" rowspan="1" colspan="1">0.00823</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003210-ChunZhi1">[77]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-100</td>
<td align="left" rowspan="1" colspan="1">1.26</td>
<td align="left" rowspan="1" colspan="1">0.03827</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003210-Maire1">[22]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-21-3p</td>
<td align="left" rowspan="1" colspan="1">1.23</td>
<td align="left" rowspan="1" colspan="1">0.03760</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003210-Namls1">[23]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-151-5p</td>
<td align="left" rowspan="1" colspan="1">1.00</td>
<td align="left" rowspan="1" colspan="1">0.00698</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pcbi.1003210-Luedde1">[78]</xref></td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p>DE microRNAs are shown with their corresponding log2 FC and FDR. A negative log2 FC indicates that microRNAs are down-regulated in high proliferative OS cells and vice versa. The references demonstrate an implication in cancer of the respective microRNA.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2b">
<title>OS proliferation-related microRNA target genes</title>
<p>To explore the functional consequences of DE microRNAs on OS cell proliferation, we determined their target genes by integrating gene expression profiles with computational predicted target genes.</p>
<p>First, the expression analysis of mRNAs resulted in a total of 666 up-regulated and 610 down-regulated mRNAs. We applied loose filter criteria for DE mRNAs without correcting for multiple tests (p-value&lt;0.05 &amp; log2 FC≥|0.7|) because microRNA regulation might lead to subtle changes in gene expression. Next, we superimposed the DE genes with predicted microRNA targets to obtain target genes affecting OS cell proliferation. We assumed that microRNAs exhibit an inverse regulatory relationship to their functional target genes, i.e. microRNA expression is inversely correlated to its target gene expression. Hence, down-regulated targets were assigned to up-regulated microRNAs in high proliferative OS cells and vice versa.</p>
<p>To exclude DE microRNAs with random association to OS cell proliferation, we tested for microRNA target gene enrichment within the list of DE genes. Among the 17 DE microRNAs, 12 are significantly enriched due to their targets (FDR&lt;0.05, <xref ref-type="supplementary-material" rid="pcbi.1003210.s008">Table S1</xref>). To account for different numbers of targets that might influence the enrichment analysis, we also computed the target gene enrichment of 1,000 permuted samples. The permutation procedure confirmed previous results (<xref ref-type="supplementary-material" rid="pcbi.1003210.s001">Figure S1</xref>). Consequently, we excluded 5 microRNAs from further analyses (<italic>miR-92b</italic>, <italic>let-7f</italic>, <italic>miR-9-3p</italic>, <italic>miR-151-5p</italic>, and <italic>miR-100</italic>). The remaining 12 OS proliferation-related microRNAs are implicated in the regulation of 474 target genes. Hierarchical clustering of the target genes resulted in a distinct separation of the high and low proliferative OS cell samples (<xref ref-type="fig" rid="pcbi-1003210-g003">Figure 3A</xref>).</p>
<fig id="pcbi-1003210-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003210.g003</object-id><label>Figure 3</label><caption>
<title>Functional implications of microRNA target genes in OS proliferation.</title>
<p>(<bold>A</bold>) Differentially expressed microRNA target genes. The heatmap shows the expression of DE microRNA target genes (log2 FC≥|0.7| &amp; p-value&lt;0.05, y-axis) among all OS cell samples (x-axis). High (dark blue) and low (light blue) proliferative OS samples are grouped into distinct clusters. The red/green color code corresponds to the expression deviation from the average expression among all samples. Complete-linkage clustering was applied with the Pearson correlation as distance metric. (<bold>B</bold>) Principal component analysis based on GO functional similarity. The figure draws the first (x-axis) and second (y-axis) principal components based on the GO functional similarity of microRNA target genes. The target genes are color coded according to their cluster membership determined by FCM. The radius of each gene represents the strength of association to its cluster. (<bold>C</bold>) Comparison of the GO enrichment analyses of the distinct clusters. Each row corresponds to a specific biological process category. The number of genes included in each category is indicated in the round brackets. Circle sizes correspond to the percentage of row-genes located in a cluster. Significantly enriched categories are color coded in red and random categories in blue.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003210.g003" position="float" xlink:type="simple"/></fig></sec><sec id="s2c">
<title>Functional clustering of microRNA targets</title>
<p>We further investigated the underlying biological processes of OS proliferation-related microRNAs. We classified microRNA target genes according to their functional similarities of their gene ontology (GO) biological process terms using fuzzy c-means clustering (FCM). After determining FCM parameters (<xref ref-type="supplementary-material" rid="pcbi.1003210.s002">Figure S2</xref>), we obtained two clusters. Principal Component Analysis (PCA) supported the results. The first two components separate the determined clusters (<xref ref-type="fig" rid="pcbi-1003210-g003">Figure 3B</xref>). Cluster C1 consists of 172 members and cluster C2 contains 212 members. The remaining 90 microRNA targets could not be annotated with a GO biological process term and were excluded from further analysis. The clustering suggested that the microRNA targets can be classified into two broad functional classes.</p>
<p>GO enrichment analyses revealed that members of C1 are mainly involved in metabolic processes like protein modification, nucleic acid metabolism, and carbohydrate metabolism, whereas members of C2 are implicated in signal transduction pathways leading to proliferation, differentiation, apoptosis, and migration. Both clusters demonstrate that cancer cells adapt metabolic processes for cell proliferation and survival <xref ref-type="bibr" rid="pcbi.1003210-Fritz1">[24]</xref>. A comparison between the five most informative GO terms (FDR&lt;0.05) illustrating the specific biological aspects of each cluster is shown in <xref ref-type="fig" rid="pcbi-1003210-g003">Figure 3C</xref>.</p>
</sec><sec id="s2d">
<title>Identifying microRNA and TF co-regulated target genes</title>
<p>Transcriptional regulation of TFs is tightly coupled with the post-transcriptional regulation of microRNAs. We utilized their 3-node and 4-node co-regulatory motifs to study DE microRNA and TF co-regulation in OS cell proliferation for each functional cluster.</p>
<p>Every possible 3-node and 4-node FFL motif was determined to assess significant microRNA and TF combinations (FDR&lt;0.2) by using the hypergeometric test (<xref ref-type="supplementary-material" rid="pcbi.1003210.s009">Table S2</xref> and <xref ref-type="supplementary-material" rid="pcbi.1003210.s010">S3</xref>). For the 3-node FFL, we obtained non-random microRNA and TF pairs with common target genes (<xref ref-type="fig" rid="pcbi-1003210-g004">Figure 4A</xref>). For 4-node FFL motifs, we assessed non-random microRNA and TF pairs that regulate gene neighbors in the protein interaction network (<xref ref-type="fig" rid="pcbi-1003210-g004">Figure 4B</xref>). The individual 3-node and 4-node FFL motifs are listed in <xref ref-type="supplementary-material" rid="pcbi.1003210.s011">Table S4</xref> and <xref ref-type="supplementary-material" rid="pcbi.1003210.s012">S5</xref>, respectively.</p>
<fig id="pcbi-1003210-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003210.g004</object-id><label>Figure 4</label><caption>
<title>MicroRNA and TF co-regulatory motifs.</title>
<p>Schematic illustration of (<bold>A</bold>) 3-node and (<bold>B</bold>) 4-node FFL motifs. A 3-node motif contains a microRNA, a TF, and a commonly regulated target gene. In contrast, 4-node FFLs comprise a microRNA, a TF, a microRNA target gene (primary target), and a TF target gene (secondary target) that interacts with the primary target. MicroRNAs are indicated with diamonds, TF with triangles, primary targets with rectangles, and secondary targets with circles. (<bold>C</bold>) Coexpression of microRNA and TF target genes. The plot shows the observed and random cumulative distribution functions (CDFs, y-axis) of the Pearson correlation coefficients (x-axis) between any gene pair regulated by a specific microRNA and TF 3-node and 4-node motif. The observed and random CDFs are compared using the KS test. The p-values are indicated within the plots. Green and orange color codes correspond to the distinct clusters C1 and C2.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003210.g004" position="float" xlink:type="simple"/></fig>
<p>Subsequently, we analyzed the co-regulated target genes of significant microRNA and TF combinations. The results are summarized in <xref ref-type="table" rid="pcbi-1003210-t003">Table 3</xref>. Noticeably, the microRNA and TF duo with the highest number of co-regulated target genes in both functional clusters is <italic>miR-9-5p</italic> and <italic>SP1</italic> (<xref ref-type="fig" rid="pcbi-1003210-g005">Figure 5</xref>) indicating a prominent role in OS cell proliferation.</p>
<fig id="pcbi-1003210-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003210.g005</object-id><label>Figure 5</label><caption>
<title><italic>miR-9-5p</italic> and <italic>SP1</italic> co-regulatory motifs.</title>
<p>The co-regulatory motifs of <italic>miR-9-5p</italic> and <italic>SP1</italic> are illustrated as graphs with nodes and edges for (<bold>A</bold>) C1 and (<bold>B</bold>) C2. MicroRNAs are marked with diamonds, TFs with triangles, primary targets with rectangle, and secondary targets with a circle. Yellow edges tag protein-DNA interactions, blue edges microRNA-target interactions, and dashed edges protein interactions. The red/green color code presents the corresponding log2 FC.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003210.g005" position="float" xlink:type="simple"/></fig><table-wrap id="pcbi-1003210-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003210.t003</object-id><label>Table 3</label><caption>
<title>Summary of proliferation-related microRNA and TF co-regulations.</title>
</caption><alternatives><graphic id="pcbi-1003210-t003-3" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003210.t003" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Cluster</td>
<td align="left" rowspan="1" colspan="1">Motif</td>
<td align="left" rowspan="1" colspan="1">microRNA</td>
<td align="left" rowspan="1" colspan="1">TF</td>
<td align="left" rowspan="1" colspan="1">Primary targets</td>
<td align="left" rowspan="1" colspan="1">Secondary targets</td>
<td align="left" rowspan="1" colspan="1">microRNA and TF pairs</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>C1</bold></td>
<td align="left" rowspan="1" colspan="1">3-node FFL</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">58</td>
<td align="left" rowspan="1" colspan="1">—</td>
<td align="left" rowspan="1" colspan="1">29</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">4-node FFL</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">69</td>
<td align="left" rowspan="1" colspan="1">227</td>
<td align="left" rowspan="1" colspan="1">23</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">total</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">29</td>
<td align="left" rowspan="1" colspan="1">85</td>
<td align="left" rowspan="1" colspan="1">213</td>
<td align="left" rowspan="1" colspan="1">46</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>C2</bold></td>
<td align="left" rowspan="1" colspan="1">3-node FFL</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">31</td>
<td align="left" rowspan="1" colspan="1">88</td>
<td align="left" rowspan="1" colspan="1">—</td>
<td align="left" rowspan="1" colspan="1">58</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">4-node FFL</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">21</td>
<td align="left" rowspan="1" colspan="1">81</td>
<td align="left" rowspan="1" colspan="1">581</td>
<td align="left" rowspan="1" colspan="1">29</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">total</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">35</td>
<td align="left" rowspan="1" colspan="1">117</td>
<td align="left" rowspan="1" colspan="1">550</td>
<td align="left" rowspan="1" colspan="1">70</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt102"><label/><p>The table specifies the number of common and interacting target genes between non-random microRNA and TF pairs for 3-node and 4-node motifs and for the total co-regulatory network they form.</p></fn></table-wrap-foot></table-wrap>
<p>Further, we examined the co-expression of genes co-regulated by the same microRNA and TF pairs. We computed the Pearson correlation coefficients between co-regulated gene pairs as a measure of their co-expression. The distribution of the resulting correlation values was compared to the correlation distribution of random genes by the Kolmogorov-Smirnov (KS) test. The co-expression of co-regulated gene pairs tends to be significantly higher than for random genes (p-value&lt;2.2×10<sup>−16</sup>, <xref ref-type="fig" rid="pcbi-1003210-g004">Figure 4C</xref>). This result supports the hypothesis of non-random microRNA and TF co-regulation within the list of their common or interacting target genes and suggests a similar functional context for their targets.</p>
</sec><sec id="s2e">
<title>Generating microRNA and TF co-regulatory networks</title>
<p>Subsequently, we constructed the microRNA and TF co-regulatory networks that highlighted the combinatorial regulation patterns and regulated biological processes of microRNAs and TFs. The networks of C1 and C2 were generated by joining all significant co-regulatory relationships of microRNAs and TFs (<xref ref-type="table" rid="pcbi-1003210-t003">Table 3</xref>). The resultant microRNA and TF co-regulatory networks are provided for full exploration on our website (<ext-link ext-link-type="uri" xlink:href="http://www.complex-systems.uni-muenster.de/co_networks.html" xlink:type="simple">http://www.complex-systems.uni-muenster.de/co_networks.html</ext-link>).</p>
<p>To assess the contribution of individual nodes in the co-regulatory networks on the networks' stability and robustness, we calculated the node degree and betweenness centrality parameters. The node degree distributions are highly right skewed. A large fraction of nodes shows a low degree and only few nodes have high degrees (<xref ref-type="supplementary-material" rid="pcbi.1003210.s003">Figure S3</xref>). Almost all microRNAs and TFs are located at higher node degrees as indicated by their average node degrees (C1: microRNAs 19 and TFs 19, C2: microRNAs 25 and TFs 49). We expected that finding as microRNA and TF co-regulation is the main subject of the present study.</p>
<p>Each network contains three types of nodes, namely microRNAs, TFs, and target genes. We ranked the nodes according to their node degrees and node type. The top 25% of microRNAs and TFs and the top 5% of target genes were considered as hubs in the C1 and C2 networks (<xref ref-type="supplementary-material" rid="pcbi.1003210.s013">Table S6</xref>). We detected the hub microRNA <italic>miR-214</italic> and the hub TFs <italic>CREB1</italic>, <italic>SP1</italic>, and <italic>ZIC2</italic> in both networks suggesting a central function in OS cell proliferation. Strikingly, around 50% of microRNA and TF target gene hubs in the two networks are TFs themselves. The microRNA and TF co-regulatory network derived from C1 contains <italic>ATF6</italic>, <italic>GTF2A1, HIVEP2, KLF5</italic>, <italic>LMO3</italic>, <italic>NFKB1</italic>, and <italic>TBPL1</italic> and the C2 network comprises <italic>BCL6, BCL6B, E2F4, HES1, JUN, LMO4, RARA, REST, SIN3A, TCF7L2</italic>, and <italic>ZBTB16</italic>. Some of these TFs (<italic>ATF6, E2F4, JUN, RARA</italic>, and <italic>REST</italic>) are implicated in building 3-node and 4-node FFL motifs in one or two networks. The remaining TFs were either not existent in the UCSC conserved TFBS track or do not produce any significant FFL. Additionally, we found epigenetic modulators and genes involved in protein modification processes, like protein ubiquitination and phosphorylation. As already mentioned, the microRNA targets in C2 are associated with signal transduction for maintaining OS cell proliferation. Among the hub genes in the network derived from C2, 30% of target gene hubs (<italic>AMOT</italic>, <italic>ARF6, CACNA1A, CTNNB1</italic>, <italic>GRB2, NOTCH1</italic>, <italic>PDGFRB</italic>, <italic>PIK3R1</italic>, <italic>SMAD7</italic>, and <italic>TGFBR2</italic>) are related to signaling pathways that participate in cell proliferation, survival, and migration.</p>
<p>Moreover, we assessed over-represented functional pathways derived from the KEGG database <xref ref-type="bibr" rid="pcbi.1003210-Kanehisa1">[25]</xref>. The enriched categories (FDR&lt;0.05) are shown in <xref ref-type="supplementary-material" rid="pcbi.1003210.s014">Table S7</xref>. We detected an enrichment of genes involved in the cell cycle and cancer related pathways in both networks. We expected to observe these functional categories as we analyzed the proliferative potential of OS tumor cell lines. Further, we observed a similar functional trend between the C1 and C2 networks as for their corresponding functional clusters. Within the co-regulatory network of C2, signaling pathways are significantly over-represented such as the <italic>MAPK</italic>-, <italic>TGFB</italic>-, and <italic>WNT</italic>-signaling pathways. In contrast, the network of C1 comprises a significant number of genes required for the basal transcription machinery.</p>
</sec><sec id="s2f">
<title>Tightly connected microRNA and TF co-regulated subnetworks</title>
<p>After examining the global co-regulation patterns of microRNAs and TFs in both networks, we were interested in sets of microRNAs and TFs that co-regulate densely connected network modules. To investigate the local structure of the OS proliferation-related co-regulatory networks, the walktrap algorithm was applied <xref ref-type="bibr" rid="pcbi.1003210-Csardi1">[26]</xref>.</p>
<p>The algorithm obtained six modules within the metabolic network of C1 (<xref ref-type="supplementary-material" rid="pcbi.1003210.s004">Figure S4</xref>) and six modules in the signaling network of C2 (<xref ref-type="supplementary-material" rid="pcbi.1003210.s005">Figure S5</xref>). The size and node types within each module are indicated in <xref ref-type="table" rid="pcbi-1003210-t004">Table 4</xref>. Strikingly, <italic>miR-9-5p</italic> is located in the largest module and is regulated through the TFs <italic>ATF2, BACH1</italic>, <italic>CREB1</italic>, and <italic>SP1</italic> in both networks. As mentioned before, <italic>miR-9-5p</italic> and <italic>SP1</italic> co-regulate the largest number of target genes and thus indicate a prominent function in OS cell proliferation.</p>
<table-wrap id="pcbi-1003210-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003210.t004</object-id><label>Table 4</label><caption>
<title>MicroRNA and TF co-regulatory subnetworks.</title>
</caption><alternatives><graphic id="pcbi-1003210-t004-4" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003210.t004" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">ID</td>
<td align="left" rowspan="1" colspan="1">microRNA</td>
<td align="left" rowspan="1" colspan="1">TF</td>
<td align="left" rowspan="1" colspan="1">nodes</td>
<td align="left" rowspan="1" colspan="1">edges</td>
<td align="left" rowspan="1" colspan="1">associated biology</td>
<td align="left" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="nt104">a</xref></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">C1.1</td>
<td align="left" rowspan="1" colspan="1">miR-221, -222, -130a, -21-5p</td>
<td align="left" rowspan="1" colspan="1">JUN, HSF2, SRF, HSF1, FOXC1, IRF7, FOXO1, YY1</td>
<td align="left" rowspan="1" colspan="1">72</td>
<td align="left" rowspan="1" colspan="1">156</td>
<td align="left" rowspan="1" colspan="1">transcription</td>
<td align="left" rowspan="1" colspan="1">2.0×10<sup>−03</sup></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">C1.2</td>
<td align="left" rowspan="1" colspan="1">miR-21-3p</td>
<td align="left" rowspan="1" colspan="1">E2F1, STAT3</td>
<td align="left" rowspan="1" colspan="1">33</td>
<td align="left" rowspan="1" colspan="1">53</td>
<td align="left" rowspan="1" colspan="1">phosphorylation</td>
<td align="left" rowspan="1" colspan="1">3.0×10<sup>−03</sup></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">C1.3</td>
<td align="left" rowspan="1" colspan="1">miR-214</td>
<td align="left" rowspan="1" colspan="1">BPTF, ZEB1, E2F4, NFIL3</td>
<td align="left" rowspan="1" colspan="1">62</td>
<td align="left" rowspan="1" colspan="1">120</td>
<td align="left" rowspan="1" colspan="1">cell cycle</td>
<td align="left" rowspan="1" colspan="1">5.6×10<sup>−03</sup></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">C1.4</td>
<td align="left" rowspan="1" colspan="1">miR-9-5p</td>
<td align="left" rowspan="1" colspan="1">CREB1, CEBPB, ATF2, SP1, ZIC2, TCF3, BACH1</td>
<td align="left" rowspan="1" colspan="1">91</td>
<td align="left" rowspan="1" colspan="1">248</td>
<td align="left" rowspan="1" colspan="1">transcription</td>
<td align="left" rowspan="1" colspan="1">1.0×10<sup>−11</sup></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">C1.5</td>
<td align="left" rowspan="1" colspan="1">miR-181a, -181b</td>
<td align="left" rowspan="1" colspan="1">MEF2A, TBP, SREBF1, MAX, POU2F1</td>
<td align="left" rowspan="1" colspan="1">60</td>
<td align="left" rowspan="1" colspan="1">142</td>
<td align="left" rowspan="1" colspan="1">chromosome organization</td>
<td align="left" rowspan="1" colspan="1">8.1×10<sup>−04</sup></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">C1.6</td>
<td align="left" rowspan="1" colspan="1">miR-138</td>
<td align="left" rowspan="1" colspan="1">MYC, KLF12</td>
<td align="left" rowspan="1" colspan="1">19</td>
<td align="left" rowspan="1" colspan="1">32</td>
<td align="left" rowspan="1" colspan="1">—</td>
<td align="left" rowspan="1" colspan="1">—</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">C2.1</td>
<td align="left" rowspan="1" colspan="1">miR-138</td>
<td align="left" rowspan="1" colspan="1">MYC, FOXC1, USF1, ZIC1, FOXJ2</td>
<td align="left" rowspan="1" colspan="1">157</td>
<td align="left" rowspan="1" colspan="1">377</td>
<td align="left" rowspan="1" colspan="1">transcription</td>
<td align="left" rowspan="1" colspan="1">1.0×10<sup>−17</sup></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">C2.2</td>
<td align="left" rowspan="1" colspan="1">miR-21-5p, -21-3p</td>
<td align="left" rowspan="1" colspan="1">STAT3, IRF9, SOX9, MEF2A</td>
<td align="left" rowspan="1" colspan="1">70</td>
<td align="left" rowspan="1" colspan="1">124</td>
<td align="left" rowspan="1" colspan="1">transport</td>
<td align="left" rowspan="1" colspan="1">5.6×10<sup>−03</sup></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">C2.3</td>
<td align="left" rowspan="1" colspan="1">miR-222, -221, -214</td>
<td align="left" rowspan="1" colspan="1">RORA, NR3C1, FOXO1</td>
<td align="left" rowspan="1" colspan="1">127</td>
<td align="left" rowspan="1" colspan="1">235</td>
<td align="left" rowspan="1" colspan="1">transcription</td>
<td align="left" rowspan="1" colspan="1">1.0×10<sup>−04</sup></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">C2.4</td>
<td align="left" rowspan="1" colspan="1">miR-130a</td>
<td align="left" rowspan="1" colspan="1">CEBPB, ZEB1, GATA2, SRF, YY1</td>
<td align="left" rowspan="1" colspan="1">87</td>
<td align="left" rowspan="1" colspan="1">144</td>
<td align="left" rowspan="1" colspan="1">differentiation</td>
<td align="left" rowspan="1" colspan="1">9.8×10<sup>−04</sup></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">C2.5</td>
<td align="left" rowspan="1" colspan="1">miR-181a, -181b</td>
<td align="left" rowspan="1" colspan="1">POU2F1, KLF12, NFIL3</td>
<td align="left" rowspan="1" colspan="1">21</td>
<td align="left" rowspan="1" colspan="1">41</td>
<td align="left" rowspan="1" colspan="1">—</td>
<td align="left" rowspan="1" colspan="1">—</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">C2.6</td>
<td align="left" rowspan="1" colspan="1">miR-9-5p</td>
<td align="left" rowspan="1" colspan="1">CREB1, TP53, NR2F2, NFIC, EGR1, ATF6, ATF2, PAX6, SREBF1, SP1, BACH1, NFATC1</td>
<td align="left" rowspan="1" colspan="1">247</td>
<td align="left" rowspan="1" colspan="1">887</td>
<td align="left" rowspan="1" colspan="1">transcription</td>
<td align="left" rowspan="1" colspan="1">4.1×10<sup>−12</sup></td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt103"><label/><p>For each module the comprised microRNAs, TFs, number of nodes and edges, and associated biological aspects with corresponding p-values are presented.</p></fn><fn id="nt104"><label>a</label><p>ES≥2.0.</p></fn><fn id="nt105"><label/><p>— no significant associated biological aspect.</p></fn></table-wrap-foot></table-wrap>
<p>Further, we run the Functional Annotation clustering Tool of the DAVID database <xref ref-type="bibr" rid="pcbi.1003210-Huang1">[27]</xref> to classify the distinct network modules according to their GO biological process and molecular function terms. We annotated each module with the biological aspect of its maximum enrichment score (ES). Among the 12 modules, five are mainly involved in transcriptional regulation processes, which is in accordance with previous studies that illustrated that microRNAs function via TFs to regulate various biological processes like cell proliferation <xref ref-type="bibr" rid="pcbi.1003210-Huang2">[28]</xref>, <xref ref-type="bibr" rid="pcbi.1003210-John1">[29]</xref>. Despite the top scored biological associations, one module (C2.1) is related to negative regulation of differentiation (ES&gt;3.9), particularly to osteoblast differentiation due to the genes <italic>CDK6</italic>, <italic>MEN1</italic>, <italic>SKI</italic>, <italic>SMAD3</italic>, and <italic>SOX2</italic>, which might provide a link to the pathogenesis of OS (<xref ref-type="supplementary-material" rid="pcbi.1003210.s005">Figure S5A</xref>). Within this module, the TF <italic>MYC</italic> (node degree 83) co-regulates several targets with <italic>miR-138</italic> (node degree 25). The top ranked target gene in this module is <italic>SIN3A</italic> (node degree 57).</p>
</sec></sec><sec id="s3">
<title>Discussion</title>
<p>OS is a complex tumor with varying degrees of genomic alterations and affected disease genes. This genomic complexity makes it difficult to identify a genetic cause and deregulated pathways in the pathogenesis of OS. Systems biological approaches provide tools to investigate the interactions between candidate genes by integrating different data sources on the network level. Thereof, cooperative or compensative effects between candidate genes might be observed. Hence, network-based approaches seemed to be ideally suited to study the implication of functional pathways in OS. This study represents the first attempt to investigate microRNA and TF co-regulatory networks in the pathogenesis of OS. In the course of the study, several data sources were integrated, namely microRNA and mRNA expression profiles, TFBS information, and protein interaction data. Therewith, we aimed to unravel possible candidate genes and their interplay that ultimately result in a high proliferative phenotype of OS cell lines. The derived microRNA and TF networks are publicly available (<ext-link ext-link-type="uri" xlink:href="http://www.complex-systems.uni-muenster.de/co_networks.html" xlink:type="simple">http://www.complex-systems.uni-muenster.de/co_networks.html</ext-link>).</p>
<sec id="s3a">
<title>OS proliferation-related microRNAs are associated with a proliferative phenotype</title>
<p>The microRNA and TF co-regulatory networks modeling OS cell proliferation are based on 12 proliferation-related microRNAs. Among these microRNAs, 11 were previously mentioned in OS <xref ref-type="bibr" rid="pcbi.1003210-Jones1">[20]</xref>, <xref ref-type="bibr" rid="pcbi.1003210-Maire1">[22]</xref>, <xref ref-type="bibr" rid="pcbi.1003210-Namls1">[23]</xref>, <xref ref-type="bibr" rid="pcbi.1003210-Ziyan1">[18]</xref>, whereas <italic>miR-138</italic> was exclusively obtained in this study. Previous studies focused on global microRNA alterations in OS with respect to osteoblast cells and bone tissue. However, microRNA expression was partially inconsistent between different studies. Namløs <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1003210-Namls1">[23]</xref> hypothesized that contradictory microRNA regulation in different genome-wide studies might be explained due to distinct differentiation stages of OS progenitor cells. In this study, the DE microRNAs were assessed between high and low proliferative OS cells. The varying proliferation activity between these cell lines might reflect distinct differentiation stages of their progenitor cells. This might explain the detection of proliferation-related microRNAs in global OS studies.</p>
<p>In different biological contexts the down-regulated microRNAs have been associated with decreased proliferation <xref ref-type="bibr" rid="pcbi.1003210-Fei1">[30]</xref>–<xref ref-type="bibr" rid="pcbi.1003210-Wang1">[33]</xref>. In turn, up-regulated microRNAs have been related to an increased proliferation potential <xref ref-type="bibr" rid="pcbi.1003210-Galardi1">[34]</xref>–<xref ref-type="bibr" rid="pcbi.1003210-Zhong1">[37]</xref>. These studies emphasize the proposed influence of the derived microRNAs on OS cell proliferation.</p>
</sec><sec id="s3b">
<title><italic>miR-9-5p</italic> and <italic>SP1</italic> co-regulated targets are highly involved in OS cell proliferation</title>
<p>The assembly of non-random microRNA and TF co-regulators revealed several interesting combinations. Based on the huge number of co-regulated target genes, the most notably co-regulation duo is the <italic>miR-9-5p</italic> and <italic>SP1</italic> pair. Depending on the derived cluster, these co-regulators seem to affect distinct functional pathways due to their target genes.</p>
<p>The C1 derived <italic>miR-9-5p</italic> and <italic>SP1</italic> co-regulated target genes seem to participate in <italic>NFKB</italic>-signaling. Commonly regulated target genes include the TFs <italic>NFKB1</italic>, <italic>NFKB2</italic>, <italic>RELA</italic>, <italic>RELB</italic>, and <italic>BCL3</italic> and the inhibitors <italic>NKRF</italic>, <italic>NFKBIA</italic>, and <italic>TNIP2</italic> that cooperatively activate or block target gene expression of <italic>NFKB</italic>, respectively <xref ref-type="bibr" rid="pcbi.1003210-Gilmore1">[38]</xref>. This pathway is implicated in OS cell proliferation <xref ref-type="bibr" rid="pcbi.1003210-Eliseev1">[39]</xref>, and <italic>NFKB1</italic> is an experimentally validated target gene of <italic>miR-9-5p</italic> <xref ref-type="bibr" rid="pcbi.1003210-Guo1">[40]</xref>. Furthermore, a regulatory circuit including <italic>SP1/NFKB1/HDAC</italic> and <italic>miR-29b</italic> is known to induce leukemic growth <xref ref-type="bibr" rid="pcbi.1003210-Liu2">[41]</xref>. Thus, <italic>miR-9-5p</italic> might function in a similar context in OS than <italic>miR-29b</italic> in leukemia.</p>
<p>On the other hand, the C2 derived <italic>miR-9-5p</italic> and <italic>SP1</italic> co-regulated genes might be involved in focal adhesion. We observed cadherins (<italic>CDH1</italic>, <italic>CDH2</italic>, <italic>DSC2</italic>, and <italic>DSG2</italic>), further cell adhesion molecules (<italic>e.g. FN1</italic>, <italic>ITGA6</italic>, <italic>ITGB1</italic>, <italic>JUP</italic>, <italic>PKP3</italic>, and <italic>VCL</italic>), and calcium signaling receptors (e.g. <italic>CACNA1A</italic> and <italic>CALR</italic>). According to StringDB <xref ref-type="bibr" rid="pcbi.1003210-Szklarczyk1">[42]</xref>, almost all commonly regulated genes interact with each other indicating a functional association (<xref ref-type="supplementary-material" rid="pcbi.1003210.s006">Figure S6</xref>). A possible pathway of <italic>miR-9-5p</italic> and <italic>SP1</italic> co-regulation could implicate <italic>CDH1</italic> and <italic>CTNNB1</italic> that modulate cell proliferation <xref ref-type="bibr" rid="pcbi.1003210-Stockinger1">[43]</xref>. <italic>CTNNB1</italic> is not a commonly regulated target gene of <italic>miR-9-5p</italic> and <italic>SP1</italic>. However, we observed some of its binding partners (e.g. <italic>CDH1</italic>, <italic>CDH3</italic>, <italic>CTNNBPI1</italic>, <italic>RUNX2</italic>, and <italic>SMAD7</italic>). Additionally, <italic>CTNNB1</italic> is a hub gene in the C2 co-regulatory network.</p>
<p>Moreover, increased expression of <italic>miR-9-5p</italic> resulted in down-regulation of the <italic>NFKB-SNAIL</italic> pathway and simultaneously to up-regulation of <italic>CDH1</italic> in melanoma cells <xref ref-type="bibr" rid="pcbi.1003210-Liu3">[44]</xref>. All these observations suggest a central role of <italic>miR-9-5p</italic> and <italic>SP1</italic> co-regulation in OS cell proliferation.</p>
</sec><sec id="s3c">
<title>Functional implications of the <italic>miR-138</italic>-<italic>MYC</italic>-<italic>SIN3A</italic> module in the pathogenesis of OS</title>
<p>Merging significant microRNA and TF co-regulators resulted in co-regulatory networks of C1 and C2. The networks provided a global view on microRNA and TF co-regulation in OS cell proliferation. To analyze the local co-regulation patterns within the networks, we specifically extracted densely connected modules. One of these modules, namely the C2.1 module, is implicated in negative regulation of differentiation, particularly osteoblast differentiation. It contains the hubs <italic>miR-138</italic>, <italic>MYC</italic>, and <italic>SIN3A</italic>. We hypothesize a function for members of C2.1 that might be specific for the pathogenesis of OS. According to StringDB <xref ref-type="bibr" rid="pcbi.1003210-Szklarczyk1">[42]</xref>, the genes in the module form a densely connected network illustrating a tight functional relationship (<xref ref-type="supplementary-material" rid="pcbi.1003210.s007">Figure S7</xref>). The module comprises members of the cell cycle (<italic>CCND1, CCND3</italic>, <italic>CDKN1A, CDKN2C</italic>, and <italic>CDK6</italic>), all involved in the <italic>RB1</italic>-pathway <xref ref-type="bibr" rid="pcbi.1003210-Knudsen1">[45]</xref>. The complex of the module members <italic>SIN3A</italic>, <italic>NCOR1</italic>, <italic>SKI</italic>, and <italic>HDAC</italic> can bind to <italic>RB1</italic> and repress <italic>E2F</italic> target genes <xref ref-type="bibr" rid="pcbi.1003210-Tokitou1">[46]</xref>. Therefrom, we assumed a connection between module members and <italic>RB1</italic>, which has been reported to be frequently deregulated in OS <xref ref-type="bibr" rid="pcbi.1003210-Scholz1">[5]</xref>.</p>
<p>Further, <italic>SIN3A</italic> is an experimentally validated target gene <italic>of miR-138</italic> <xref ref-type="bibr" rid="pcbi.1003210-Ramachandran1">[47]</xref>. In the global co-regulatory network of C2 as well as in C2.1 module, it depicts a hub gene. Its role in cancer is contradictory, on the one hand it shows tumor suppressor functions <xref ref-type="bibr" rid="pcbi.1003210-Suzuki1">[48]</xref>. On the other hand, it acts in tumor growth <xref ref-type="bibr" rid="pcbi.1003210-Dannenberg1">[49]</xref>. Taken together with the fact that <italic>SIN3A</italic> can interact with <italic>RB1</italic>, we suggest a possible role for <italic>SIN3A</italic> in the pathogenesis of OS.</p>
</sec><sec id="s3d">
<title>Model of OS cell proliferation</title>
<p>After examining and discussing the structural and functional aspects of the co-regulatory networks, we integrated the main results of the present study into a potential model of OS cell proliferation (<xref ref-type="fig" rid="pcbi-1003210-g006">Figure 6</xref>). The focus of the model is on microRNA and TF co-regulation of the microRNAs <italic>miR-9-5p</italic>, <italic>miR-138</italic>, and <italic>miR-214</italic> and the TFs <italic>SP1</italic> and <italic>MYC</italic>.</p>
<fig id="pcbi-1003210-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003210.g006</object-id><label>Figure 6</label><caption>
<title>Model of OS cell proliferation.</title>
<p>The picture illustrates the proposed model of OS cell proliferation co-regulated by <italic>miR-9-5p</italic>, <italic>miR-138</italic>, and <italic>miR-214</italic> and the TFs <italic>SP1</italic> and <italic>MYC</italic>. These regulators control mainly components of the <italic>NFKB</italic>- and <italic>RB1</italic>-pathway and of focal adhesion processes. Primary microRNA targets are rectangular and secondary targets are ellipse shaped. Red marks up-regulated genes in proliferative active OS cell lines and green indicates down-regulated genes. White nodes represent genes not DE in OS cell proliferation. Solid and dashed arrows illustrate direct and indirect functional associations, respectively. <italic>RB1</italic> is shaded in red to indicate that it is no member of the global networks.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003210.g006" position="float" xlink:type="simple"/></fig>
<p>In proliferative active OS cell lines, <italic>miR-9-5p</italic>, <italic>miR-138</italic>, and <italic>miR-214</italic> are significantly down-regulated leading to the up-regulation of their direct target genes <italic>CDK6</italic>, <italic>E2F4</italic>, <italic>HES1</italic>, <italic>ITGA6</italic>, <italic>NFKB1</italic>, <italic>NOTCH1</italic>, and <italic>SIN3A</italic>. <italic>CDK6</italic> phosphorylates <italic>RB1</italic> and therewith the <italic>RB1</italic>/<italic>SIN3A</italic>/<italic>SKI</italic>/<italic>NCOR1</italic>/<italic>HDAC</italic> complex cannot repress <italic>E2F4</italic> target gene expression <xref ref-type="bibr" rid="pcbi.1003210-Knudsen1">[45]</xref>, <xref ref-type="bibr" rid="pcbi.1003210-Tokitou1">[46]</xref>. Activated <italic>NOTCH1</italic> induces <italic>HES1</italic> and sustains <italic>NFKB</italic>-signaling through <italic>NFKB1</italic>, <italic>NFKB2</italic>, <italic>RELA</italic>, <italic>RELB</italic> <xref ref-type="bibr" rid="pcbi.1003210-Espinosa1">[50]</xref>. <italic>CTNNB1</italic> stabilizes cell-cell adhesions in complex with <italic>CDH1</italic>. Unbound <italic>CTNNB1</italic> can translocate to the nucleus <xref ref-type="bibr" rid="pcbi.1003210-Stockinger1">[43]</xref>. All these signals end up in the nucleus where they induce expression of proliferation promoting genes like microRNAs up-regulated in high proliferative OS cells, CCND1, and FN1. In turn, they repress genes implicated in growth-arrest.</p>
</sec><sec id="s3e">
<title>Conclusion</title>
<p>The resulting microRNA and TF co-regulatory networks display a detailed picture of the regulation of OS cell proliferation. In the present study, we concentrated on distinct functional aspects unraveled from the networks. The outcome suggests that down-regulation of <italic>miR-9-5p</italic>, <italic>miR-138</italic>, and <italic>miR-214</italic> results in a strong proliferative phenotype of OS cells due to their impact on <italic>NFKB</italic>- and <italic>RB1</italic>-signaling and on focal adhesion.</p>
<p>Our study provides potential therapeutic targets in OS and proposes concepts for further research. In addition, we demonstrated how systems biological approaches support the analyses of complex diseases.</p>
</sec></sec><sec id="s4" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s4a">
<title>Data sets</title>
<p>We used microRNA and mRNA expression data of seven authenticated OS cell lines, six from our previously published study <xref ref-type="bibr" rid="pcbi.1003210-Baumhoer1">[16]</xref> and one additional (ZK-58). Prior to microarray analyses, RNA was isolated and further processed as described in <xref ref-type="bibr" rid="pcbi.1003210-Baumhoer1">[16]</xref>. MicroRNA and mRNA expression profiles were determined on Exiqon's miRCURY LNA and Affymetrix's Human Gene 1ST arrays, respectively.</p>
<p>Conserved TFBSs (hg19) were downloaded from the UCSC Table Browser <xref ref-type="bibr" rid="pcbi.1003210-Kent1">[51]</xref>. The track contained predicted TFBSs conserved in the human/mouse/rat alignment that were determined by using the Transfac Matrix Database 7.0 <xref ref-type="bibr" rid="pcbi.1003210-Matys1">[52]</xref>. Protein interaction data were obtained from BioGRID release 3.1.92 <xref ref-type="bibr" rid="pcbi.1003210-Breitkreutz1">[53]</xref>.</p>
</sec><sec id="s4b">
<title>Proliferation assay to group OS cell lines</title>
<p>The OS cell lines were evaluated regarding their proliferative, migrative, and invasive potential by using in vitro-assays (BD Biosciences). Cells utilized in the assays showed 60 to 80% confluence growth. Prior to the assays cell lines were synchronized to ensure a uniform cell growth.</p>
<p>To analyze OS cell proliferation, duplicates of each cell line (1×10<sup>5</sup> cells) were seeded in 25 cm<sup>2</sup> cell culture flasks. Cells were harvested at 24, 48, 72, 96, and 168 hours of growth. The cell number was determined by an automated cell counter (Beckman Coulter). For each cell line and time point, the mean cell number was calculated to estimate the growth rate and subsequently the doubling time.</p>
<p>Further, the Biocoat Matrigel Invasion Assay and a migration assay (BD Biosciences) were performed for each cell line in duplicate with matrigel-coated and uncoated inserts, respectively. Experiments were performed according to the manufacturer's instructions. Evaluation of invaded and migrated cells was done after 24 and 48 hours by light-microscopic analysis. Ten visual fields (magnification 10×) were analyzed by counting stained cells on the membranes.</p>
</sec><sec id="s4c">
<title>Expression analysis of microRNAs and mRNAs</title>
<p>The expression data sets were analyzed using the Bioconductor package limma <xref ref-type="bibr" rid="pcbi.1003210-Smyth1">[54]</xref>. DE genes between high and low proliferative OS cells were determined using eBayes <xref ref-type="bibr" rid="pcbi.1003210-Smyth1">[54]</xref>.</p>
<p>MicroRNA expression data were annotated with miRBase release 18 <xref ref-type="bibr" rid="pcbi.1003210-GriffithsJones1">[55]</xref>, background corrected by normexp+offset 10 <xref ref-type="bibr" rid="pcbi.1003210-Ritchie1">[56]</xref>, and normalized with printtiploess followed by RQuant <xref ref-type="bibr" rid="pcbi.1003210-Yang1">[57]</xref>. In the differential expression analysis we considered the top 75% of microRNA probes that showed largest variation over all samples. Multiple test correction was performed using Benjamini and Hochberg's FDR approach <xref ref-type="bibr" rid="pcbi.1003210-Benjamini1">[58]</xref>.</p>
<p>The mRNA expression data were preprocessed by the Bioconductor package affy <xref ref-type="bibr" rid="pcbi.1003210-Gautier1">[59]</xref>. The Affymetrix Human Gene 1 ST array contains probes mapping among the whole transcript. Therefore, we filtered probes that mapped to exons present in at least 80% of a gene's transcripts to get one stable expression value per gene. Transcripts were derived from Ensembl release 63 <xref ref-type="bibr" rid="pcbi.1003210-Flicek1">[60]</xref>. The raw probe intensities were background corrected, normalized, and summarized to the gene-level by applying the robust multi-array average algorithm (rma) <xref ref-type="bibr" rid="pcbi.1003210-Gautier1">[59]</xref>.</p>
</sec><sec id="s4d">
<title>MicroRNA and TF target prediction</title>
<p>Predicted microRNA targets were obtained by running the local perl scripts targetscan_60.pl and targetscan_61_context_scores.pl that were online available at the TargetScan website (<ext-link ext-link-type="uri" xlink:href="http://www.targetscan.org/" xlink:type="simple">http://www.targetscan.org/</ext-link>) <xref ref-type="bibr" rid="pcbi.1003210-Grimson1">[61]</xref>. Mature microRNA sequences were downloaded from miRBase release 18 <xref ref-type="bibr" rid="pcbi.1003210-GriffithsJones1">[55]</xref>. To derive high efficacy targets, we filtered target predictions with a context score≤−0.1 <xref ref-type="bibr" rid="pcbi.1003210-Grimson1">[61]</xref>.</p>
<p>To determine TF target genes, we downloaded the transcriptional start sites (TSSs) of all genes included in the mRNA expression data set from the hg19 assembly of the UCSC Table Browser <xref ref-type="bibr" rid="pcbi.1003210-Kent1">[51]</xref> and the TSSs from our proliferation related microRNA genes from miRStart <xref ref-type="bibr" rid="pcbi.1003210-Chien1">[62]</xref>. Further, we defined the promoter region to −/+ 2000 nucleotides around the TSSs. Genes having a TFBS that completely overlapped their promoter regions were considered as TF targets. We just considered human TFs that were expressed in at least one proliferation group of our OS cell samples (log2 intensity≥8).</p>
</sec><sec id="s4e">
<title>Enrichment of microRNA target genes</title>
<p>To assess the enrichment of microRNA target genes in the list of DE genes, a hypergeometric test was performed. Multiple test correction was done by determining the FDR according to Benjamini and Hochberg <xref ref-type="bibr" rid="pcbi.1003210-Benjamini1">[58]</xref>. To account for the different number of target genes of the DE microRNAs, a permutation procedure was applied. We randomly selected the number of DE genes out of the genes in our mRNA expression data set and counted the number of random microRNA target genes. For each permutation an enrichment score (ES, -log10 p-value) was calculated. The permutation procedure was repeated 1,000 times. The resulting permutation p-values were obtained by counting the number of permuted ESs exceeding the observed one. This was done for all DE microRNAs separately.</p>
</sec><sec id="s4f">
<title>Fuzzy c-means clustering of DE microRNA targets</title>
<p>To classify DE microRNA targets according to their functional similarity, their GO semantic similarity scores based on biological process terms were computed using Resnik's information content approach of the GOSim package <xref ref-type="bibr" rid="pcbi.1003210-Frhlich1">[63]</xref>. The resulting functional similarity scores for any target gene pair were listed in a similarity matrix, which was further utilized as distance matrix for clustering. We applied FCM <xref ref-type="bibr" rid="pcbi.1003210-Kaufman1">[64]</xref> to classify microRNA target genes according to their functional similarity using the function fanny from the R cluster package <xref ref-type="bibr" rid="pcbi.1003210-Maechler1">[65]</xref>. The fuzziness parameter was estimated by Dunn's coefficient <xref ref-type="bibr" rid="pcbi.1003210-Trauwaert1">[66]</xref> among a range of 1.1 to 1.5 and the cluster number was estimated over a range of 2 to 15 using Dunn's index <xref ref-type="bibr" rid="pcbi.1003210-Haldiki1">[67]</xref>. The Dunn coefficient (range 0–1) indicates the fuzziness of a cluster <xref ref-type="bibr" rid="pcbi.1003210-Trauwaert1">[66]</xref>. The Dunn index compared the between cluster variation to the within cluster variation and measures the cluster separation. A Dunn index &gt;1 indicates a satisfying clustering <xref ref-type="bibr" rid="pcbi.1003210-Haldiki1">[67]</xref>.</p>
<p>The derived functional clusters were evaluated by running a GO enrichment analysis with the Bioconductor package GOStats <xref ref-type="bibr" rid="pcbi.1003210-Falcon1">[68]</xref>. Multiple test correction was performed by using Benjamini and Hochberg's FDR approach <xref ref-type="bibr" rid="pcbi.1003210-Benjamini1">[58]</xref>.</p>
</sec><sec id="s4g">
<title>Testing and evaluating microRNA and TF co-regulation</title>
<p>We tested for non-random microRNA and TF 3-node and 4-node motifs by using the hypergeometric test adapted from Sun <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1003210-Sun1">[14]</xref>. In contrast to them, we applied a different null model to derive p-values specific for the underlying microRNA and TF co-regulation pairs.</p>
<p>For the 3-node motifs we tested if a microRNA and TF pair had significantly more commonly DE target genes than computationally predicted target genes. In turn, co-regulation of microRNA and TF pairs in 4-node motifs was tested based on commonly regulated secondary target genes and compared to the genes with corresponding TFBS in the whole 1<sup>st</sup>-neighbor protein interaction network. The 1<sup>st</sup>-neighbor protein interaction network was determined by extracting all 1<sup>st</sup>-neighbors of microRNA target genes from the protein interaction data. Benjamini and Hochberg's FDR was used to adjust for multiple testing <xref ref-type="bibr" rid="pcbi.1003210-Benjamini1">[58]</xref>.</p>
<p>Furthermore, evaluation of significant pairs of microRNAs and TFs was performed by assessing the coexpression of genes targeted by the same microRNA and TF pair. The Pearson correlation was used as a measure for coexpression. Statistical significance was determined by a permutation procedure. We randomly chose the same number of genes targeted by 3-node and 4-node FFLs out of all genes annotated in the mRNA expression data and computed their correlation coefficients. The permutation procedure was repeated 1,000 times. Finally, we tested if the coexpression of the genes in the FFLs was significantly greater than in randomly selected gene pairs using the KS test.</p>
</sec><sec id="s4h">
<title>MicroRNA and TF co-regulatory network generation and analyses</title>
<p>The microRNA and TF co-regulatory networks were constructed by merging all 3-node and 4-node FFL motifs. The networks were modeled as graphs with nodes and edges. Nodes corresponded to microRNAs, TFs, or target genes and edges corresponded to microRNA-target regulation, TF-target regulation, or protein interactions. To identify crucial network players, we computed network centralities, namely node degree and betweenness, using the R package igraph <xref ref-type="bibr" rid="pcbi.1003210-Csardi1">[26]</xref>. The node degree is defined as the number of direct neighbors of a node in a network. Nodes having a high number of direct neighbors are thought to be important regulatory hubs inside the network. In contrast, a node's betweenness is a measure of the number of shortest paths between any pair of nodes that run through it <xref ref-type="bibr" rid="pcbi.1003210-He1">[69]</xref>.</p>
<p>To detect tightly connected groups of nodes in the network, we run the walktrap algorithm <xref ref-type="bibr" rid="pcbi.1003210-Pons1">[70]</xref>. This algorithm finds modules in connected graphs. It is based on random walks and assumes that the random walker is trapped in dense parts of a network <xref ref-type="bibr" rid="pcbi.1003210-Csardi1">[26]</xref>.</p>
<p>For further network evaluation we used the Functional Annotation Tool of the DAVID database <xref ref-type="bibr" rid="pcbi.1003210-Huang1">[27]</xref>. The networks were visualized with Cytoscape 2.8.3 <xref ref-type="bibr" rid="pcbi.1003210-Smoot1">[71]</xref> and Cytoscape Web 1.0.2 <xref ref-type="bibr" rid="pcbi.1003210-Lopes1">[72]</xref>.</p>
</sec></sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pcbi.1003210.s001" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pcbi.1003210.s001" position="float" xlink:type="simple"><label>Figure S1</label><caption>
<p><bold>Enrichment of proliferation-related microRNAs.</bold> The barplot of enrichment scores (ESs) of observed microRNA target genes (cyan) and randomly selected targets (grey). The ES of randomly selected microRNA targets is illustrated as mean±stdev. Per microRNA we computed 1,000 random ESs. P-values between observed and random ESs were obtained by counting the number of random ESs exceeding the observed one.</p>
<p>(PDF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003210.s002" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pcbi.1003210.s002" position="float" xlink:type="simple"><label>Figure S2</label><caption>
<p><bold>Distribution of Dunn coefficients and indices determined by FCM clustering.</bold> (<bold>A</bold>) Assessing the optimal fuzziness parameter. The plot illustrates the Dunn coefficients (y-axis) among a range of fuzziness parameters (x-axis) for different cluster numbers. The fuzziness was set to 1.1, where the Dunn coefficient distribution exceeds 0.5 for all cluster numbers. (<bold>B</bold>) Determining the optimal cluster number. The plot shows the Dunn indices (y-axis) among a range of cluster numbers (x-axis) for different fuzziness parameters. The optimal cluster number was set to 2, where the Dunn index reached its maximum value.</p>
<p>(PDF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003210.s003" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pcbi.1003210.s003" position="float" xlink:type="simple"><label>Figure S3</label><caption>
<p><bold>Node degree distribution of the microRNA and TF co-regulatory networks.</bold> The plots show the fraction of proteins (y-axis) among all node degrees (x-axis) from the microRNA and TF co-regulatory networks (grey) of (<bold>A</bold>) C1 and (<bold>B</bold>) C2. Different colors indicate distinct degree distributions of different node types. Horizontal lines mark the average node degree of individual node types. The values of the average node degrees are listed in the plots' legends.</p>
<p>(PDF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003210.s004" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pcbi.1003210.s004" position="float" xlink:type="simple"><label>Figure S4</label><caption>
<p><bold>MicroRNA and TF co-regulatory network modules derived from C1.</bold> The figure shows network modules defined by the walktrap algorithm. The modules C1.1 to C2.6 are labeled from (<bold>A</bold>) to (<bold>F</bold>). Node shapes correspond to the distinct node types: microRNAs (diamond), TFs (triangle), primary target (rectangle), and secondary target (ellipse). Yellow edges mark TF-DNA interactions, blue edges microRNA-target interactions, and dashed grey edges protein interactions. The red/green color code indicates the log2 FC.</p>
<p>(PDF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003210.s005" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pcbi.1003210.s005" position="float" xlink:type="simple"><label>Figure S5</label><caption>
<p><bold>MicroRNA and TF co-regulatory network modules derived from C2.</bold> The figure shows network modules defined by the walktrap algorithm. The modules C2.1 to C2.6 are labeled from (<bold>A</bold>) to (<bold>F</bold>). Node shapes correspond to the distinct node types: microRNAs (diamond), TFs (triangle), primary target (rectangle), and secondary target (ellipse). Yellow edges mark TF-DNA interactions, blue edges microRNA-target interactions, and dashed grey edges protein interactions. The red/green color code indicates the log2 FC. The C2.1 module implicated in negative regulation of differentiation of osteoblast cells is tagged with a red frame.</p>
<p>(PDF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003210.s006" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pcbi.1003210.s006" position="float" xlink:type="simple"><label>Figure S6</label><caption>
<p><bold><italic>miR-9-5p</italic></bold><bold> and </bold><bold><italic>SP1</italic></bold><bold> target gene associations.</bold> The network is derived from the STRING 9.0 database <xref ref-type="bibr" rid="pcbi.1003210-Szklarczyk1">[42]</xref>. It illustrates experimental and literature-mined functional associations between <italic>miR-9-5p</italic> and <italic>SP1</italic> target genes.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003210.s007" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pcbi.1003210.s007" position="float" xlink:type="simple"><label>Figure S7</label><caption>
<p><bold>Module C2.1 target gene associations.</bold> The network is derived from the STRING 9.0 database <xref ref-type="bibr" rid="pcbi.1003210-Szklarczyk1">[42]</xref>. It illustrates experimental and literature-mined functional associations between genes within the C2.1 network module.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003210.s008" mimetype="application/vnd.ms-excel" xlink:href="info:doi/10.1371/journal.pcbi.1003210.s008" position="float" xlink:type="simple"><label>Table S1</label><caption>
<p><bold>Enrichment of proliferation-related microRNA target genes.</bold> <xref ref-type="sec" rid="s2">Results</xref> of the hypergeometric test to examine significantly enriched microRNA target genes within the list of DE genes. The table marks the total number of predicted target genes, the number of DE target genes, and the corresponding FDR.</p>
<p>(XLS)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003210.s009" mimetype="application/vnd.ms-excel" xlink:href="info:doi/10.1371/journal.pcbi.1003210.s009" position="float" xlink:type="simple"><label>Table S2</label><caption>
<p><bold>Significant microRNA and TF co-regulatory 3-node motifs.</bold> The table summarizes the number of common target genes of each non-random microRNA and TF co-regulatory pair with corresponding statistics.</p>
<p>(XLS)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003210.s010" mimetype="application/vnd.ms-excel" xlink:href="info:doi/10.1371/journal.pcbi.1003210.s010" position="float" xlink:type="simple"><label>Table S3</label><caption>
<p><bold>Significant microRNA and TF co-regulatory 4-node motifs.</bold> The table summarizes the number of interacting target genes of each non-random microRNA and TF co-regulatory pair with corresponding statistics.</p>
<p>(XLS)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003210.s011" mimetype="application/vnd.ms-excel" xlink:href="info:doi/10.1371/journal.pcbi.1003210.s011" position="float" xlink:type="simple"><label>Table S4</label><caption>
<p><bold>Individual microRNA and TF co-regulatory 3-node and 4-node motifs of C1.</bold></p>
<p>(XLS)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003210.s012" mimetype="application/vnd.ms-excel" xlink:href="info:doi/10.1371/journal.pcbi.1003210.s012" position="float" xlink:type="simple"><label>Table S5</label><caption>
<p><bold>Individual microRNA and TF co-regulatory 3-node and 4-node motifs of C2.</bold></p>
<p>(XLS)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003210.s013" mimetype="application/vnd.ms-excel" xlink:href="info:doi/10.1371/journal.pcbi.1003210.s013" position="float" xlink:type="simple"><label>Table S6</label><caption>
<p><bold>MicroRNA and TF co-regulatory network hubs.</bold> The table holds the node degree and betweenness parameters of hub genes within the co-regulatory network of C1 and C2 for each node type.</p>
<p>(XLS)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003210.s014" mimetype="application/vnd.ms-excel" xlink:href="info:doi/10.1371/journal.pcbi.1003210.s014" position="float" xlink:type="simple"><label>Table S7</label><caption>
<p><bold>Over-represented KEGG pathways.</bold></p>
<p>(XLS)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pcbi.1003210-Picci1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Picci</surname><given-names>P</given-names></name> (<year>2007</year>) <article-title>Osteosarcoma (osteogenic sarcoma)</article-title>. <source>Orphanet J Rare Dis</source> <volume>2</volume>: <fpage>6</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Man1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Man</surname><given-names>T-K</given-names></name>, <name name-style="western"><surname>Chintagumpala</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Visvanathan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Perlaky</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Expression profiles of osteosarcoma that can predict response to chemotherapy</article-title>. <source>Cancer Res</source> <volume>65</volume>: <fpage>8142</fpage>–<lpage>8150</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Ozaki1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ozaki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Schaefer</surname><given-names>K-L</given-names></name>, <name name-style="western"><surname>Wai</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Buerger</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Flege</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas</article-title>. <source>Int J Cancer</source> <volume>102</volume>: <fpage>355</fpage>–<lpage>365</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Smida1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Smida</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Baumhoer</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Rosemann</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Walch</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bielack</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma</article-title>. <source>Clin Cancer Res</source> <volume>16</volume>: <fpage>4256</fpage>–<lpage>4267</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Scholz1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Scholz</surname><given-names>RB</given-names></name>, <name name-style="western"><surname>Kabisch</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Weber</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Röser</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Delling</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>1992</year>) <article-title>Studies of the RB1 gene and the p53 gene in human osteosarcomas</article-title>. <source>Pediatr Hemat Oncol</source> <volume>9</volume>: <fpage>125</fpage>–<lpage>137</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Ueda1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ueda</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Healey</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Huvos</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Ladanyi</surname><given-names>M</given-names></name> (<year>1997</year>) <article-title>Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone</article-title>. <source>Sarcoma</source> <volume>1</volume>: <fpage>131</fpage>–<lpage>134</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Selbach1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Selbach</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Schwanhäusser</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Thierfelder</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Khanin</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Widespread changes in protein synthesis induced by microRNAs</article-title>. <source>Nature</source> <volume>455</volume>: <fpage>58</fpage>–<lpage>63</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Friedman1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Friedman</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Farh</surname><given-names>KK-H</given-names></name>, <name name-style="western"><surname>Burge</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Bartel</surname><given-names>DP</given-names></name> (<year>2009</year>) <article-title>Most mammalian mRNAs are conserved targets of microRNAs</article-title>. <source>Genome Res</source> <volume>19</volume>: <fpage>92</fpage>–<lpage>105</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Davis1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davis</surname><given-names>BN</given-names></name>, <name name-style="western"><surname>Hata</surname><given-names>A</given-names></name> (<year>2009</year>) <article-title>Regulation of MicroRNA Biogenesis: A miRiad of mechanisms</article-title>. <source>Cell Commun Signal</source> <volume>7</volume>: <fpage>18</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-EsquelaKerscher1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Esquela-Kerscher</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Slack</surname><given-names>FJ</given-names></name> (<year>2006</year>) <article-title>Oncomirs - microRNAs with a role in cancer</article-title>. <source>Nat Rev Cancer</source> <volume>6</volume>: <fpage>259</fpage>–<lpage>269</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Calin1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Calin</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Sevignani</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Dumitru</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Hyslop</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Noch</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers</article-title>. <source>P Natl Acad Sci USA</source> <volume>101</volume>: <fpage>2999</fpage>–<lpage>3004</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Hobert1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hobert</surname><given-names>O</given-names></name> (<year>2008</year>) <article-title>Gene regulation by transcription factors and microRNAs</article-title>. <source>Science</source> <volume>319</volume>: <fpage>1785</fpage>–<lpage>1786</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Shalgi1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shalgi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lieber</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Oren</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pilpel</surname><given-names>Y</given-names></name> (<year>2007</year>) <article-title>Global and local architecture of the mammalian microRNA-transcription factor regulatory network</article-title>. <source>PLoS Comput Biol</source> <volume>3</volume>: <fpage>e131</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Sun1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sun</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gong</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Purow</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name> (<year>2012</year>) <article-title>Uncovering MicroRNA and Transcription Factor Mediated Regulatory Networks in Glioblastoma</article-title>. <source>PLoS Comput Biol</source> <volume>8</volume>: <fpage>e1002488</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Zhang1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Tong</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2</article-title>. <source>Oncol Rep</source> <volume>24</volume>: <fpage>1363</fpage>–<lpage>1369</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Baumhoer1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baumhoer</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Zillmer</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Unger</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Rosemann</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Atkinson</surname><given-names>MJ</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in Osteosarcoma</article-title>. <source>Cancer Genet</source> <volume>205</volume>: <fpage>212</fpage>–<lpage>219</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Duan1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duan</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Choy</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Harmon</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Susa</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>MicroRNA-199a-3p is downregulated in human Osteosarcoma and regulates cell proliferation and migration</article-title>. <source>Mol Cancer Ther</source> <volume>10</volume>: <fpage>1337</fpage>–<lpage>1345</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Ziyan1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ziyan</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Shuhua</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xiufang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Xiaoyun</surname><given-names>L</given-names></name> (<year>2011</year>) <article-title>MicroRNA-21 is involved in osteosarcoma cell invasion and migration</article-title>. <source>Med Oncol</source> <volume>28</volume>: <fpage>1469</fpage>–<lpage>1474</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Liu1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3</article-title>. <source>Biochem Bioph Res Co</source> <volume>416</volume>: <fpage>31</fpage>–<lpage>38</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Jones1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jones</surname><given-names>KB</given-names></name>, <name name-style="western"><surname>Salah</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Del Mare</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Galasso</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gaudio</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>miRNA signatures associate with pathogenesis and progression of osteosarcoma</article-title>. <source>Cancer Res</source> <volume>72</volume>: <fpage>1865</fpage>–<lpage>1877</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Lulla1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lulla</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>FF</given-names></name>, <name name-style="western"><surname>Bischof</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Chou</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>F Bonaldo M</surname><given-names>de</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Identification of Differentially Expressed MicroRNAs in Osteosarcoma</article-title>. <source>Sarcoma</source> <volume>2011</volume>: <fpage>732690</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Maire1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Maire</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Yoshimoto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chilton-MacNeill</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zielenska</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma</article-title>. <source>Cancer Genet</source> <volume>204</volume>: <fpage>138</fpage>–<lpage>146</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Namls1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Namløs</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Meza-Zepeda</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Barøy</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ostensen</surname><given-names>IHG</given-names></name>, <name name-style="western"><surname>Kresse</surname><given-names>SH</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs</article-title>. <source>PLoS One</source> <volume>7</volume>: <fpage>e48086</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Fritz1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fritz</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Fajas</surname><given-names>L</given-names></name> (<year>2010</year>) <article-title>Metabolism and proliferation share common regulatory pathways in cancer cells</article-title>. <source>Oncogene</source> <volume>29</volume>: <fpage>4369</fpage>–<lpage>4377</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Kanehisa1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kanehisa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Goto</surname><given-names>S</given-names></name> (<year>2000</year>) <article-title>KEGG: kyoto encyclopedia of genes and genomes</article-title>. <source>Nucleic Acids Res</source> <volume>28</volume>: <fpage>27</fpage>–<lpage>30</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Csardi1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Csardi</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Nepusz</surname><given-names>T</given-names></name> (<year>2006</year>) <article-title>The igraph software package for complex network research</article-title>. <source>Inter Journal Complex Systems</source> <fpage>1695</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Huang1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Sherman</surname><given-names>BT</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Collins</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Alvord</surname><given-names>WG</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists</article-title>. <source>Genome Biol</source> <volume>8</volume>: <fpage>R183</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Huang2"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>H-C</given-names></name>, <name name-style="western"><surname>Chiang</surname><given-names>C-W</given-names></name>, <name name-style="western"><surname>Yeh</surname><given-names>C-T</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>S-J</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Identification of a two-layer regulatory network of proliferation-related microRNAs in hepatoma cells</article-title>. <source>Nucleic Acids Res</source> <volume>40</volume>: <fpage>10478</fpage>–<lpage>10493</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-John1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>John</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Enright</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Aravin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tuschl</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sander</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Human MicroRNA targets</article-title>. <source>PLoS Biol</source> <volume>2</volume>: <fpage>e363</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Fei1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fei</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>X</given-names></name> (<year>2012</year>) <article-title>miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML)</article-title>. <source>PLoS One</source> <volume>7</volume>: <fpage>e32834</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Peng1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peng</surname><given-names>R-Q</given-names></name>, <name name-style="western"><surname>Wan</surname><given-names>H-Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H-F</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7</article-title>. <source>J Biol Chem</source> <volume>287</volume>: <fpage>14301</fpage>–<lpage>14309</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Selcuklu1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Selcuklu</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Donoghue</surname><given-names>MTA</given-names></name>, <name name-style="western"><surname>Rehmet</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Souza Gomes</surname><given-names>Mde</given-names></name>, <name name-style="western"><surname>Fort</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells</article-title>. <source>J Biol Chem</source> <volume>287</volume>: <fpage>29516</fpage>–<lpage>29528</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Wang1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>L-J</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>Y-X</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Qi</surname><given-names>Z-T</given-names></name> (<year>2012</year>) <article-title>MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma</article-title>. <source>Carcinogenesis</source> <volume>33</volume>: <fpage>1113</fpage>–<lpage>1120</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Galardi1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Galardi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mercatelli</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Giorda</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Massalini</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Frajese</surname><given-names>GV</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1</article-title>. <source>J Biol Chem</source> <volume>282</volume>: <fpage>23716</fpage>–<lpage>23724</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Wu1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname><given-names>W-H</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>C-P</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X-P</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W-F</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X-W</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension</article-title>. <source>Am J Hypertens</source> <volume>24</volume>: <fpage>1087</fpage>–<lpage>1093</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Xie1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xie</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hao</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma</article-title>. <source>Cancer</source> <volume>118</volume>: <fpage>2431</fpage>–<lpage>2442</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Zhong1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhong</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gong</surname><given-names>Z</given-names></name> (<year>2012</year>) <article-title>miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer</article-title>. <source>J Cancer Res Clin Oncol</source> <volume>138</volume>: <fpage>1781</fpage>–<lpage>1788</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Gilmore1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gilmore</surname><given-names>TD</given-names></name> (<year>2006</year>) <article-title>Introduction to NF-kappaB: players, pathways, perspectives</article-title>. <source>Oncogene</source> <volume>25</volume>: <fpage>6680</fpage>–<lpage>6684</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Eliseev1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eliseev</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Zuscik</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Schwarz</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>O'Keefe</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Drissi</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Increased radiation-induced apoptosis of Saos2 cells via inhibition of NFkappaB: a role for c-Jun N-terminal kinase</article-title>. <source>J Cell Biochem</source> <volume>96</volume>: <fpage>1262</fpage>–<lpage>1273</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Guo1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guo</surname><given-names>L-M</given-names></name>, <name name-style="western"><surname>Pu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y-X</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1</article-title>. <source>FEBS J</source> <volume>276</volume>: <fpage>5537</fpage>–<lpage>5546</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Liu2"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>L-C</given-names></name>, <name name-style="western"><surname>Pang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Santhanam</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Schwind</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia</article-title>. <source>Cancer Cell</source> <volume>17</volume>: <fpage>333</fpage>–<lpage>347</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Szklarczyk1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Szklarczyk</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Franceschini</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kuhn</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Simonovic</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Roth</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored</article-title>. <source>Nucleic Acids Res</source> <volume>39</volume>: <fpage>D561</fpage>–<lpage>D568</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Stockinger1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stockinger</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Eger</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Beug</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Foisner</surname><given-names>R</given-names></name> (<year>2001</year>) <article-title>E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity</article-title>. <source>J Cell Biol</source> <volume>154</volume>: <fpage>1185</fpage>–<lpage>1196</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Liu3"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma</article-title>. <source>J Pathol</source> <volume>226</volume>: <fpage>61</fpage>–<lpage>72</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Knudsen1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Knudsen</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>JYJ</given-names></name> (<year>2010</year>) <article-title>Targeting the RB-pathway in cancer therapy</article-title>. <source>Clin Cancer Res</source> <volume>16</volume>: <fpage>1094</fpage>–<lpage>1099</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Tokitou1"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tokitou</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Nomura</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Kaul</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Wadhwa</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Viral ski inhibits retinoblastoma protein (Rb)-mediated transcriptional repression in a dominant negative fashion</article-title>. <source>J Biol Chem</source> <volume>274</volume>: <fpage>4485</fpage>–<lpage>4488</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Ramachandran1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ramachandran</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Karp</surname><given-names>PH</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ostedgaard</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Walz</surname><given-names>AE</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>A microRNA network regulates expression and biosynthesis of wild-type and DeltaF508 mutant cystic fibrosis transmembrane conductance regulator</article-title>. <source>P Natl Acad Sci USA</source> <volume>109</volume>: <fpage>13362</fpage>–<lpage>13367</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Suzuki1"><label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Suzuki</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ouchida</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yano</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Toyooka</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Decreased expression of the SIN3A gene, a candidate tumor suppressor located at the prevalent allelic loss region 15q23 in non-small cell lung cancer</article-title>. <source>Lung Cancer</source> <volume>59</volume>: <fpage>24</fpage>–<lpage>31</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Dannenberg1"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dannenberg</surname><given-names>J-H</given-names></name>, <name name-style="western"><surname>David</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Torre J van</surname><given-names>der</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>WH</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival</article-title>. <source>Genes Dev</source> <volume>19</volume>: <fpage>1581</fpage>–<lpage>1595</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Espinosa1"><label>50</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Espinosa</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Cathelin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>D'Altri</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Trimarchi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Statnikov</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia</article-title>. <source>Cancer Cell</source> <volume>18</volume>: <fpage>268</fpage>–<lpage>281</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Kent1"><label>51</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kent</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Sugnet</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Furey</surname><given-names>TS</given-names></name>, <name name-style="western"><surname>Roskin</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Pringle</surname><given-names>TH</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>The human genome browser at UCSC</article-title>. <source>Genome Res</source> <volume>12</volume>: <fpage>996</fpage>–<lpage>1006</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Matys1"><label>52</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Matys</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Kel-Margoulis</surname><given-names>OV</given-names></name>, <name name-style="western"><surname>Fricke</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Liebich</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Land</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes</article-title>. <source>Nucleic Acids Res</source> <volume>34</volume>: <fpage>D108</fpage>–<lpage>D110</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Breitkreutz1"><label>53</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Breitkreutz</surname><given-names>B-J</given-names></name>, <name name-style="western"><surname>Stark</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Tyers</surname><given-names>M</given-names></name> (<year>2003</year>) <article-title>The GRID: The General Repository for Interaction Datasets</article-title>. <source>Genome Biol</source> <volume>3</volume>: <fpage>R23</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Smyth1"><label>54</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Smyth</surname><given-names>GK</given-names></name> (<year>2004</year>) <article-title>Linear models and empirical bayes methods for assessing differential expression in microarray experiments</article-title>. <source>Stat Appl Genet Mol</source> <volume>3</volume>: <fpage>Article3</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-GriffithsJones1"><label>55</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Griffiths-Jones</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Grocock</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Dongen S</surname><given-names>van</given-names></name>, <name name-style="western"><surname>Bateman</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Enright</surname><given-names>AJ</given-names></name> (<year>2006</year>) <article-title>miRBase: microRNA sequences, targets and gene nomenclature</article-title>. <source>Nucleic Acids Res</source> <volume>34</volume>: <fpage>D140</fpage>–<lpage>D144</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Ritchie1"><label>56</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ritchie</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Silver</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Oshlack</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Holmes</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Diyagama</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>A comparison of background correction methods for two-colour microarrays</article-title>. <source>Bioinformatics</source> <volume>23</volume>: <fpage>2700</fpage>–<lpage>2707</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Yang1"><label>57</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Dudoit</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Luu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>V</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation</article-title>. <source>Nucleic Acids Res</source> <volume>30</volume>: <fpage>e15</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Benjamini1"><label>58</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Benjamini</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Hochberg</surname><given-names>Y</given-names></name> (<year>1995</year>) <article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title>. <source>J R Stat Soc</source> <volume>57</volume>: <fpage>289</fpage>–<lpage>300</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Gautier1"><label>59</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gautier</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Cope</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Bolstad</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Irizarry</surname><given-names>RA</given-names></name> (<year>2004</year>) <article-title>affy–analysis of Affymetrix GeneChip data at the probe level</article-title>. <source>Bioinformatics</source> <volume>20</volume>: <fpage>307</fpage>–<lpage>315</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Flicek1"><label>60</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Flicek</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Amode</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Barrell</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Beal</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Brent</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Ensembl 2011</article-title>. <source>Nucleic Acids Res</source> <volume>39</volume>: <fpage>D800</fpage>–<lpage>D806</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Grimson1"><label>61</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grimson</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Farh</surname><given-names>KK-H</given-names></name>, <name name-style="western"><surname>Johnston</surname><given-names>WK</given-names></name>, <name name-style="western"><surname>Garrett-Engele</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>LP</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing</article-title>. <source>Mol Cell</source> <volume>27</volume>: <fpage>91</fpage>–<lpage>105</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Chien1"><label>62</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chien</surname><given-names>C-H</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>Y-M</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>W-C</given-names></name>, <name name-style="western"><surname>Chiang-Hsieh</surname><given-names>P-Y</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>T-Y</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Identifying transcriptional start sites of human microRNAs based on high-throughput sequencing data</article-title>. <source>Nucleic Acids Res</source> <volume>39</volume>: <fpage>9345</fpage>–<lpage>9356</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Frhlich1"><label>63</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fröhlich</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Speer</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Poustka</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Beissbarth</surname><given-names>T</given-names></name> (<year>2007</year>) <article-title>GOSim–an R-package for computation of information theoretic GO similarities between terms and gene products</article-title>. <source>BMC Bioinformatics</source> <volume>8</volume>: <fpage>166</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Kaufman1"><label>64</label>
<mixed-citation publication-type="other" xlink:type="simple">Kaufman L, Rousseeuw PJ (1990) Finding Groups in Data: An Introduction to Cluster Analysis. Wiley.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Maechler1"><label>65</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Maechler</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rousseeuw</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Struyf</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hubert</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hornik</surname><given-names>K</given-names></name> (<year>2012</year>) <article-title>cluster: Cluster Analysis Basics and Extensions, R package version 1.14.3</article-title>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Trauwaert1"><label>66</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Trauwaert</surname><given-names>E</given-names></name> (<year>1988</year>) <article-title>On the meaning of Dunn's partition coefficient for fuzzy clusters</article-title>. <source>Fuzzy Set Syst</source> <volume>25</volume>: <fpage>217</fpage>–<lpage>242</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Haldiki1"><label>67</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haldiki</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Batistakis</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Vazirgiannis</surname><given-names>M</given-names></name> (<year>2002</year>) <article-title>Cluster validity methods</article-title>. <source>SIGMOD</source> <volume>31</volume>: <fpage>40</fpage>–<lpage>45</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Falcon1"><label>68</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Falcon</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gentleman</surname><given-names>R</given-names></name> (<year>2007</year>) <article-title>Using GOstats to test gene lists for GO term association</article-title>. <source>Bioinformatics</source> <volume>23</volume>: <fpage>257</fpage>–<lpage>258</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-He1"><label>69</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>He</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name> (<year>2006</year>) <article-title>Why do hubs tend to be essential in protein networks?</article-title> <source>PLoS Genet</source> <volume>2</volume>: <fpage>e88</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Pons1"><label>70</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pons</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Latapy</surname><given-names>M</given-names></name> (<year>2006</year>) <article-title>Computing communities in large networks using random walks</article-title>. <source>JGAA</source> <volume>10</volume>: <fpage>191</fpage>–<lpage>218</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Smoot1"><label>71</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Smoot</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Ono</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ruscheinski</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>P-L</given-names></name>, <name name-style="western"><surname>Ideker</surname><given-names>T</given-names></name> (<year>2011</year>) <article-title>Cytoscape 2.8: new features for data integration and network visualization</article-title>. <source>Bioinformatics</source> <volume>27</volume>: <fpage>431</fpage>–<lpage>432</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Lopes1"><label>72</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lopes</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Franz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kazi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Donaldson</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Morris</surname><given-names>Q</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Cytoscape Web: an interactive web-based network browser</article-title>. <source>Bioinformatics</source> <volume>26</volume>: <fpage>2347</fpage>–<lpage>2348</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Boyerinas1"><label>73</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boyerinas</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>S-M</given-names></name>, <name name-style="western"><surname>Hau</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Murmann</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Peter</surname><given-names>ME</given-names></name> (<year>2010</year>) <article-title>The role of let-7 in cell differentiation and cancer</article-title>. <source>Endocr Relat Cancer</source> <volume>17</volume>: <fpage>F19</fpage>–<lpage>F36</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Haug1"><label>74</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haug</surname><given-names>BH</given-names></name>, <name name-style="western"><surname>Henriksen</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Buechner</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Geerts</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Tømte</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma</article-title>. <source>Carcinogenesis</source> <volume>32</volume>: <fpage>1005</fpage>–<lpage>1012</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Wang2"><label>75</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>X-C</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>L-L</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>H-L</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>X-Y</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>L-Q</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Expression of miRNA-130a in nonsmall cell lung cancer</article-title>. <source>Am J Med Sci</source> <volume>340</volume>: <fpage>385</fpage>–<lpage>388</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Jiang1"><label>76</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jiang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H-W</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>M-H</given-names></name>, <name name-style="western"><surname>He</surname><given-names>X-H</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene</article-title>. <source>Cancer Res</source> <volume>70</volume>: <fpage>3119</fpage>–<lpage>3127</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-ChunZhi1"><label>77</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chun-Zhi</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Lei</surname><given-names>H</given-names></name>, <name name-style="western"><surname>An-Ling</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Yan-Chao</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN</article-title>. <source>BMC Cancer</source> <volume>10</volume>: <fpage>367</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003210-Luedde1"><label>78</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Luedde</surname><given-names>T</given-names></name> (<year>2010</year>) <article-title>MicroRNA-151 and its hosting gene FAK (focal adhesion kinase) regulate tumor cell migration and spreading of hepatocellular carcinoma</article-title>. <source>Hepatology</source> <volume>52</volume>: <fpage>1164</fpage>–<lpage>1166</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>